DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 894 filers reported holding DANAHER CORPORATION in Q1 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $13,945,000 | -5.0% | 53,990 | -6.7% | 0.34% | +3.3% |
Q2 2022 | $14,677,000 | -14.0% | 57,890 | -0.5% | 0.33% | +0.3% |
Q1 2022 | $17,069,000 | -13.0% | 58,191 | -2.5% | 0.33% | -9.5% |
Q4 2021 | $19,630,000 | +7.2% | 59,660 | -0.8% | 0.37% | +14.3% |
Q3 2021 | $18,310,000 | +2.3% | 60,141 | -9.9% | 0.32% | +9.2% |
Q2 2021 | $17,904,000 | +14.4% | 66,718 | -4.1% | 0.30% | +6.1% |
Q1 2021 | $15,655,000 | -2.0% | 69,551 | -3.3% | 0.28% | 0.0% |
Q4 2020 | $15,981,000 | -1.4% | 71,945 | -4.4% | 0.28% | -35.3% |
Q3 2020 | $16,208,000 | +20.3% | 75,271 | -1.2% | 0.43% | +11.4% |
Q2 2020 | $13,473,000 | +19.2% | 76,192 | -6.7% | 0.39% | +2.9% |
Q1 2020 | $11,301,000 | -18.2% | 81,649 | -9.3% | 0.38% | +5.0% |
Q4 2019 | $13,812,000 | -2.3% | 89,997 | -8.1% | 0.36% | -9.2% |
Q3 2019 | $14,143,000 | +12.3% | 97,925 | +11.1% | 0.39% | +11.3% |
Q2 2019 | $12,593,000 | +3.9% | 88,118 | -4.0% | 0.35% | +1.1% |
Q1 2019 | $12,117,000 | +23.7% | 91,779 | -3.3% | 0.35% | +13.3% |
Q4 2018 | $9,792,000 | -8.5% | 94,953 | -3.6% | 0.31% | 0.0% |
Q3 2018 | $10,704,000 | +6.1% | 98,502 | -3.6% | 0.31% | -1.0% |
Q2 2018 | $10,085,000 | -6.0% | 102,201 | -6.8% | 0.31% | -4.0% |
Q1 2018 | $10,734,000 | -1.0% | 109,637 | -6.1% | 0.32% | +2.5% |
Q4 2017 | $10,839,000 | +3.4% | 116,777 | -4.4% | 0.32% | -4.8% |
Q3 2017 | $10,482,000 | -0.3% | 122,195 | -2.0% | 0.33% | -1.2% |
Q2 2017 | $10,517,000 | -1.2% | 124,631 | +0.1% | 0.34% | -4.0% |
Q1 2017 | $10,647,000 | +2.9% | 124,489 | -6.4% | 0.35% | +1.7% |
Q4 2016 | $10,350,000 | -5.9% | 132,974 | -5.3% | 0.34% | -7.8% |
Q3 2016 | $11,002,000 | -40.2% | 140,348 | -23.0% | 0.37% | -41.8% |
Q2 2016 | $18,407,000 | +9.7% | 182,250 | +3.1% | 0.64% | +7.7% |
Q1 2016 | $16,777,000 | +6.3% | 176,854 | +4.1% | 0.60% | +4.6% |
Q4 2015 | $15,784,000 | +21.8% | 169,944 | +11.8% | 0.57% | +17.6% |
Q3 2015 | $12,958,000 | +7.9% | 152,060 | +8.3% | 0.48% | +18.9% |
Q2 2015 | $12,014,000 | +1.6% | 140,366 | +0.8% | 0.41% | +3.6% |
Q1 2015 | $11,826,000 | -1.2% | 139,300 | -0.2% | 0.39% | -1.5% |
Q4 2014 | $11,967,000 | +7.7% | 139,617 | -4.5% | 0.40% | +7.0% |
Q3 2014 | $11,109,000 | -4.9% | 146,199 | -1.5% | 0.37% | -2.1% |
Q2 2014 | $11,685,000 | +5.1% | 148,415 | +0.1% | 0.38% | +1.6% |
Q1 2014 | $11,118,000 | -22.1% | 148,237 | -19.8% | 0.38% | -20.4% |
Q4 2013 | $14,278,000 | +7.0% | 184,923 | -3.9% | 0.47% | +2.8% |
Q3 2013 | $13,338,000 | -9.6% | 192,400 | -17.5% | 0.46% | +55.8% |
Q2 2013 | $14,762,000 | -5.9% | 233,189 | -11.7% | 0.29% | -3.9% |
Q1 2013 | $15,695,000 | +6.8% | 264,114 | +0.5% | 0.31% | +1.0% |
Q4 2012 | $14,698,000 | +14.0% | 262,918 | +12.5% | 0.30% | +3.1% |
Q3 2012 | $12,893,000 | +19.9% | 233,770 | +13.2% | 0.29% | +7.7% |
Q2 2012 | $10,755,000 | -12.7% | 206,506 | -6.2% | 0.27% | -11.4% |
Q1 2012 | $12,325,000 | +11.1% | 220,087 | -6.7% | 0.31% | +6.9% |
Q4 2011 | $11,091,000 | +2.9% | 235,782 | -8.2% | 0.29% | -7.7% |
Q3 2011 | $10,777,000 | -23.9% | 256,967 | -3.9% | 0.31% | -10.9% |
Q2 2011 | $14,169,000 | +6.2% | 267,367 | +4.0% | 0.35% | +5.7% |
Q1 2011 | $13,337,000 | +11.6% | 256,993 | +1.4% | 0.33% | +5.1% |
Q4 2010 | $11,954,000 | – | 253,458 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |